Logo

Sorrento Reports Results of COVISTIX COVID-19 Test to Detects Omicron Variant

Share this

Sorrento Reports Results of COVISTIX COVID-19 Test to Detects Omicron Variant

Shots:

  • The company reported the initial lab results of its COVISTIX COVID-19 virus rapid antigen detection test which showed its ability to detect Omicron variant along with the original SARS-CoV-2 virus and other VOCs
  • In a laboratory setting, COVISTIX can detect the Omicron N protein at a lower level over other COVID-19 rapid antigen tests that were EUA approved and commercially available. Additionally, COVISTIX demonstrated ~20% higher sensitivity in a real-world clinical study including asymptomatic patients
  • COVISTIX is currently approved in Mexico, Brazil and is CE marked in the EU. The company is currently building up its manufacturing capacity in the US

Ref: Globe Newswire | Image: Sorrento

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions